REFERENCES
- Mašek K., Seifert J., Flegel M., Krojidlo M., Kolínský J. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide. Meth. Find. Exp. Clin. Pharmacol. 1984; 6: 667
- Masihi K. N., Lange W., Rohde-Schulz B., Mašek K. Antiviral activity of immunomodulator adamantylamide dipeptide. Int. J. Immunother. 1987; 3: 89
- Masihi K. N., Lange W., Schwenke W., Gast G., Hushhorn P., Palache B., Mašek K. Effect of immunomodulatorv adamantylamide dipeptide on antibody response to influenza subunit vaccines and protection against aerosol influenza infection. Vaccine 1990; 8: 159
- Masihi K. N., Rohde-Schulz B., Mašek K., Palache B. Antiviral and adjuvant activity of immunomodulator adamantylamide dipeptide, in Microbial Infections, H. Friedman. Plenum Press, New York 1993; 275
- Masihi K. N., Mašek K. Effect of the synthetic immunomodulator adamantylamide dipeptide on replication of human immunodeficiency virus alone or in combination with azidothymidine. Int. J. Immunother 1993; 9: 143
- Franěk J., Malina J. Immunomodulatory capacity of drugs evaluated in a mouse model of Klebsiella pneumoniae infection, in Immunotherapeutical Prospects of Infectious Diseases, K. N. Masihi, W. Lange. Springer Verlag, Berlin, Heidelberg 1990; 55
- Farghali H., Buchar E., Jiřička Z., Kameníková L., Janků I., Mašek K. The hepatoprotective effects of a new immunomodulator adamantylamide dipeptide on carbon tetrachloride toxicity in rats. Highlights Modern Biochem. 1989; 2: 1539
- Mašek K. Immunopharmacological properties of synthetic muramyl peptides and their analogs, in Immunomodulators and Non-specific Host Defence Mechanisms against Microbial Infections. Adv. Biosci. 1988; 68: 11, edited by K.N. Masihi and W. Lange
- Vacek A., Rotkovská D., Bartoníčková A. Radioprotection of hemopoiesis conferred by aqueous extract from chlorococcal algae (Ivastimul) administered to mice before irradiation. Exp. Hematol. 1990; 18: 234
- Hofer M., Vacek A., Mašek K., Juchelková L., Pipalová I. Adamantylamide dipeptide stimulates hematopoiesis and increases survival in irradiated mice. Int. J. Immunopharmac. 2000; 22: 91
- Tavassoli M., Friedenstein A. Hemopoietic stromal microenvironment. Am. J. Hematol. 1983; 15: 195
- Spooncer E., Eliason J., Dexter T. M. Long-term mouse bone marrow cultures, in Haemopoiesis: A Practical Approach, N. G. Testa, G. Molineux. Oxford University Press, Oxford, New York, Tokyo 1993; 55
- Vacek A., Hofer M., Mašek K. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan. Immunopharmacol. Immunotoxicol. 1999; 21: 1
- Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukins 2, 3, 4 or 5 using modified cDNA vectors. Eur. J. Immunol. 1988; 18: 97
- Song Z. X., Quesenberry P. J. Radioresistant murine marrow stromal cells: a morphologic and functional characterization. Exp. Hematol. 1984; 12: 523
- Versele S. R.M., van den Heuvel R. L., Schoeters G. E.R., Vanderborght O. L.J. Proliferation activity of stromal stem cells (CFUf) from hemopoietic organs of pre- and postnatal mice. Radiat. Res. 1987; 11: 185
- Sullivan A. K., Claxton D., Shematek G., Wang H. Cellular composition of rat bone marrow stroma. Antigen-defined subpopulations. Lab. Invest. 1989; 60: 667
- Patchen M. L., MacVittie T. J. Use of glucan to enhance hemopoietic recovery after exposure to cobalt-60 irradiation, in Macrophages and Natural Killer Cells, S. J. Normann, J. Sorkin. Plenum Press, New York 1982; 267
- Pospíšil M., Hofer M., Pipalová I., Viklická Š, Netíková J., Šandula J. Enhancement of hematopoietic recovery in gamma-irradiated mice by the joint use of diclofenac, an inhibitor of prostaglandin production, and glucan, a macrophage activator. Exp. Hematol. 1992; 20: 891